Repairogen Corporation is a biotechnology startup founded in 2012, specializing in anti-aging skincare technology. The company has attracted significant attention, having secured a $1.00M Seed Round investment on 16 September 2017 from Kairos Ventures, Hudson Valley Startup Fund, and Big Red Ventures. The company's proprietary technology is based on a platform developed at an ivy-league medical research institution, aiming to disrupt the skincare industry. Repairogen focuses on developing premium anti-aging skincare ingredients and products, leveraging their innovative technology. Their core scientific innovation significantly enhances the natural DNA-repair process in skin cells, targeting the root cause of skin aging by addressing DNA damage. This approach has the potential to tackle various skin aging issues such as wrinkles, dark spots, dryness, and lack of elasticity. The innovative and scientifically proven technology utilized by Repairogen holds promise in providing customers with healthier and younger-looking skin, aligning with the growing demands in the Health Care and Wellness Beauty industries. With a strong financial backing from notable investors, Repairogen is well-positioned to drive further advancements in the skincare sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $1.00M | 3 |
|
16 Sep 2017 |
| Seed Round | $460.00K | 5 |
|
03 Jan 2014 |
No recent news or press coverage available for Repairogen Corporation.
We care about your data, and we'd love to use cookies make your experience better.
